Allergan PLC. (AGN) Shares Bought by Teacher Retirement System of Texas
Teacher Retirement System of Texas boosted its holdings in Allergan PLC. (NYSE:AGN) by 0.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 306,000 shares of the company’s stock after acquiring an additional 2,504 shares during the period. Teacher Retirement System of Texas owned 0.09% of Allergan PLC. worth $74,386,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of AGN. Enterprise Financial Services Corp raised its stake in Allergan PLC. by 62.7% in the 1st quarter. Enterprise Financial Services Corp now owns 462 shares of the company’s stock valued at $110,000 after acquiring an additional 178 shares during the period. Jacobi Capital Management LLC grew its holdings in Allergan PLC. by 4.9% in the 1st quarter. Jacobi Capital Management LLC now owns 472 shares of the company’s stock valued at $112,000 after buying an additional 22 shares in the last quarter. JNBA Financial Advisors grew its holdings in Allergan PLC. by 2.5% in the 1st quarter. JNBA Financial Advisors now owns 487 shares of the company’s stock valued at $116,000 after buying an additional 12 shares in the last quarter. Webster Bank N. A. grew its holdings in Allergan PLC. by 31.0% in the 1st quarter. Webster Bank N. A. now owns 520 shares of the company’s stock valued at $124,000 after buying an additional 123 shares in the last quarter. Finally, Pacific Center for Financial Services grew its holdings in Allergan PLC. by 805.1% in the 1st quarter. Pacific Center for Financial Services now owns 534 shares of the company’s stock valued at $128,000 after buying an additional 475 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.
Shares of Allergan PLC. (NYSE AGN) opened at 227.73 on Tuesday. The company has a 50-day moving average price of $238.12 and a 200 day moving average price of $237.88. The firm has a market capitalization of $76.13 billion, a price-to-earnings ratio of 6.94 and a beta of 1.18. Allergan PLC. has a 1-year low of $184.50 and a 1-year high of $256.80.
Allergan PLC. (NYSE:AGN) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $4.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.95 by $0.07. Allergan PLC. had a return on equity of 7.37% and a net margin of 79.17%. The firm had revenue of $4.01 billion during the quarter, compared to analysts’ expectations of $3.95 billion. During the same period in the prior year, the business earned $3.35 EPS. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities research analysts predict that Allergan PLC. will post $16.27 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Friday, August 18th will be issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date of this dividend is Wednesday, August 16th. Allergan PLC.’s payout ratio is currently 9.95%.
A number of research analysts have commented on AGN shares. Royal Bank Of Canada upped their price objective on Allergan PLC. from $279.00 to $284.00 and gave the company an “outperform” rating in a report on Wednesday, May 10th. Goldman Sachs Group, Inc. (The) lowered Allergan PLC. from a “buy” rating to a “neutral” rating and set a $262.00 price objective on the stock. in a report on Wednesday, May 10th. UBS Group AG reaffirmed a “buy” rating and issued a $275.00 price objective on shares of Allergan PLC. in a report on Monday, May 15th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Allergan PLC. in a report on Thursday, May 25th. Finally, ValuEngine lowered Allergan PLC. from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $275.49.
TRADEMARK VIOLATION WARNING: This news story was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://theolympiareport.com/2017/09/05/allergan-plc-agn-shares-bought-by-teacher-retirement-system-of-texas.html.
Allergan PLC. Profile
Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.
Want to see what other hedge funds are holding AGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allergan PLC. (NYSE:AGN).
Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with Analyst Ratings Network's FREE daily email newsletter.